Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs.
Publication
, Journal Article
Millington, DS; Bali, DM
Published in: Mol Genet Metab Rep
June 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Mol Genet Metab Rep
DOI
ISSN
2214-4269
Publication Date
June 2017
Volume
11
Start / End Page
72 / 73
Location
United States
Related Subject Headings
- 3202 Clinical sciences
- 3105 Genetics
- 0604 Genetics
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Millington, D. S., & Bali, D. M. (2017). Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs. Mol Genet Metab Rep, 11, 72–73. https://doi.org/10.1016/j.ymgmr.2017.04.009
Millington, David S., and Deeksha M. Bali. “Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs.” Mol Genet Metab Rep 11 (June 2017): 72–73. https://doi.org/10.1016/j.ymgmr.2017.04.009.
Millington DS, Bali DM. Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs. Mol Genet Metab Rep. 2017 Jun;11:72–3.
Millington, David S., and Deeksha M. Bali. “Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs.” Mol Genet Metab Rep, vol. 11, June 2017, pp. 72–73. Pubmed, doi:10.1016/j.ymgmr.2017.04.009.
Millington DS, Bali DM. Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs. Mol Genet Metab Rep. 2017 Jun;11:72–73.
Published In
Mol Genet Metab Rep
DOI
ISSN
2214-4269
Publication Date
June 2017
Volume
11
Start / End Page
72 / 73
Location
United States
Related Subject Headings
- 3202 Clinical sciences
- 3105 Genetics
- 0604 Genetics
- 0601 Biochemistry and Cell Biology